Bio & Pharma
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer drug...
Oct 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&rs...
Oct 24, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wit...
Oct 23, 2023 (Gmt+09:00)
4 Min read -
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient in...
Oct 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next year...
Oct 23, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Samsung Bioepis releases Soliris biosimilar in Europe
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, is rolling out its latest product Epysqli, ...
Oct 19, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Daewoong Pharma's GER drug gets product OK from Mexico
South Korea’s Daewoong Pharmaceutical on Wednesday said its gastroesophageal reflux (GER) disease drug Fexuclue (active ingredient fexuprazan h...
Oct 19, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for hos...
Oct 18, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Zuellig mulls acquiring S.Korea’s top drug distributor Geo-Young
Asia’s leading drug distributor Zuellig Pharma is considering the acquisition of Geo-Young Corp., the largest medicine wholesaler in South Kore...
Oct 18, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Foo...
Oct 18, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Red ginseng proven to treat drug addiction: Research
It has been revealed that red ginseng significantly improves drug addiction and withdrawal symptoms caused by substance abuse. The research results c...
Oct 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Johnson & Johnson more interested in Korean bio startups
Johnson & Johnson, a global pharmaceutical giant, showed more interest in South Korean bio startups with competitive innovation despite the recen...
Oct 17, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
HLB gets global rights to Chinese liver cancer drug
South Korea’s HLB Therapeutics Co. on Tuesday said its US subsidiary Elevar Therapeutics has acquired the global rights excluding South Korea ...
Oct 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Noul to export $1.4 mn in malaria diagnostic kits to Angola
South Korean in-vitro diagnostics maker Noul Co. has signed an exclusive sales deal in Angola on the company’s malaria diagnostic platform wort...
Oct 17, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
GI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho....
Oct 16, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease b...
Oct 16, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
S.Korea's DuChemBio localizes core materials of radiopharmaceuticals
South Korea's DuChemBio Co. announced on Thursday that it has obtained final approval for a recovery and purification facility for oxygen-18 concentr...
Oct 12, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of cooper...
Oct 12, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Noul releases AI-based diagnostic gizmo for cervical cancer
Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer dia...
Oct 11, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
NGeneBio joins US gov't Cancer Moonshot project
South Korean medical diagnostic company NGeneBio Co. announced on Tuesday it joins US President Joe Biden's cancer-conquering project "Cancer Moonsho...
Oct 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
SK Plasma gets investment from Indonesian fund
South Korea’s SK Plasma on Tuesday said it signed a term sheet, or a nonbinding agreement on the basic terms and conditions of an investment, w...
Oct 10, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy ...
Oct 06, 2023 (Gmt+09:00)
3 Min read -
Bio & Pharma
Ildong Pharma to spin off R&D subsidiary in Nov
South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1. The ...
Oct 06, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Lotte Biologics to break ground on 1st local CDMO plant in 2024
South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liters...
Oct 05, 2023 (Gmt+09:00)
2 Min read -
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Global...
Oct 05, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtaine...
Sep 27, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
NeoCannBio completes $7.4 mn series B funding
South Korea's NeoCannBio, a medical cannabis startup backed by the Korea Institute of Science and Technology (KIST), announced on Tuesday that it has...
Sep 26, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion gets sales approval for Yuflyma in Japan
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labour...
Sep 26, 2023 (Gmt+09:00)
1 Min read -
Bio & Pharma
Celltrion signs largest-ever quarterly deal with global sales affiliate
Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its largest...
Sep 25, 2023 (Gmt+09:00)
2 Min read
Hidden Champions
-
DCM
Published: Dec 09, 2022
Last updated: Jan 30, 2023
-
Buhmwoo Group
Published: Apr 21, 2021
Last updated: Jan 30, 2023
-
T-Robotics
Published: Mar 25, 2021
Last updated: Jan 30, 2023
-
Koh Young Technology Inc
Published: Sep 21, 2020
Last updated: Jan 20, 2023
-
Point Mobile
Published: Sep 14, 2021
Last updated: May 10, 2022
Future Unicorns
Latest News